Hackensack University Medical Center; Pediatric Rheumatology

Hackensack, New Jersey 07601

0 studies enrolling now · 4 studies all time

What they study most

Juvenile Idiopathic Arthritis

Studies at this site

• Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis — Completed
• A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) — Completed
• A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis — Completed
• A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis — Completed